231. COVID-19: Epidemiology and Screening: Saturday, 12:15 - 1:30 p.m.
Poster Session: COVID-19: Epidemiology and Screening
Scott L. DuVall, PhD (he/him/his)
Director, VA Informatics and Computing Infrastructure
Department of Veterans Affairs and University of Utah School of Medicine
Salt Lake City, Utah, United States
Julie A. Lynch, PhD, RN, MBA; ORCID: 0000-0003-0108-2127
Department of Veterans Affairs Salt Lake City Health Care System, University of Utah School of Medicine
Salt Lake City, Utah, United States
Patrick R. Alba, MS
Department of Veterans Affairs
New York, New York, United States
Michael E. Matheny, MD, MPH, MS, FACMI
Department of Veterans Affairs
Nashville, Tennessee, United States
Marc A. Suchard, MD, PhD
Department of Veterans Affairs
Los Angeles, California, United States
Amanda R. Shields, BA
Ikaika Health
Chapel Hill, North Carolina, United States
Aaron W C Kamauu, MD, MS, MPH
Managing Director
Ikaika Health
Bountiful, Utah, United States
Lisa Glasser, MD
Vaccines and Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA
Wilmington, Delaware, United States
Catia Ferreira, MSc, PhD
AstraZeneca
Wilmington, Delaware, United States
Sudhir Venkatesan, BDS, MPH, PhD
AstraZeenca
Cambridge, England, United Kingdom
Carla Talarico, PhD, MPH
Vaccines and Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA
Gaithersburg, Maryland, United States
Sylvia Taylor, PhD, MPH, MBA
Medical Evidence, Vaccines and Immune Therapies Unit, AstraZeneca, Cambridge, UK
Cambridge, England, United Kingdom